David Kotler

Dechert Survey of Securities Fraud Class Actions Brought Against U.S. Life Sciences Companies

Publicly Traded Life Sciences Companies in the United States Remain an Increasingly Popular Target of Securities Fraud Class Action Lawsuits: The past year was particularly noteworthy with respect to the absolute and...more

3/20/2013 - Amgen Inc. v Connecticut Retirement Plans Class Action FDA Fraud Life Sciences Marketing Off-Label Promotion Pharmaceutical Securities Fraud